Form 4: Kalaris Therapeutics Director Akkaraju Reports Acquisition of 11,444,503 Shares Following Merger

Director Srinivas Akkaraju reports acquiring 11,444,503 shares of Kalaris Therapeutics following the merger with Kalaris Tx, Inc.

Summary

• Srinivas Akkaraju, a director and 10% owner of Kalaris Therapeutics, Inc. (KLRS), reported a transaction on March 18, 2025.
• Akkaraju acquired 11,444,503 shares of common stock due to the merger between Kalaris Therapeutics, Inc. and Kalaris Tx, Inc.
• The shares were issued upon the closing of the merger contemplated by the Agreement and Plan of Merger dated November 7, 2024.
• The merger involved Aurora Merger Sub, Inc., a wholly-owned subsidiary of Kalaris Therapeutics, Inc., and Kalaris Tx, Inc.
• Each share of KTx common stock was converted into the right to receive 0.2016 shares of Kalaris Therapeutics common stock.
• Akkaraju indirectly owns these shares through Samsara BioCapital, L.P., where he has voting and investment power.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the document primarily reports a transaction related to a merger. It doesn't inherently convey positive or negative information about the company's performance.

Positives

• The merger's completion suggests a strategic move to consolidate operations or technologies.
• Akkaraju's increased stake could signal confidence in the merged entity's future prospects.

Risks

• The document does not provide information on the financial health or future performance of the merged entity.
• The disclaimer of beneficial ownership by Akkaraju, except for his pecuniary interest, could indicate a complex ownership structure.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading and provide investors with insights into the actions of company insiders.

Stakeholder Impact

• Shareholders may be interested in the increased holdings of a director, potentially signaling confidence.
• The merger itself could impact employees and customers depending on the integration process.

Key Dates